Chlamydia trachomatis Infection in Female Partners of Circumcised and Uncircumcised Adult Men
|
|
- Darleen Weaver
- 6 years ago
- Views:
Transcription
1 American Journal of Epidemiology Advance Access published September 21, 2005 American Journal of Epidemiology Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. Vol. 162, No. 9 DOI: /aje/kwi284 Original Contribution Chlamydia trachomatis Infection in Female Partners of Circumcised and Uncircumcised Adult Men Xavier Castellsagué 1, Rosanna W. Peeling 2, Silvia Franceschi 3, Silvia de Sanjosé 1, Jennifer S. Smith 4, Ginesa Albero 1, Mireia Díaz 1, Rolando Herrero 5, Nubia Muñoz 1, and F. Xavier Bosch 1 for the IARC Multicenter Cervical Cancer Study Group 1 Cancer Epidemiology and Registration Unit, Institut d Investigació Biomèdica de Bellvitge (IDIBELL), Institut Català d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain. 2 National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Canada. 3 Epidemiology and Biology Cluster, International Agency for Research on Cancer, Lyon, France. 4 Department of Epidemiology, University of North Carolina, Chapel Hill, NC. 5 Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), San José, Costa Rica. Received for publication February 13, 2005; accepted for publication May 25, Male circumcision has been shown to reduce the risk of acquiring and transmitting a number of venereal infections. However, little is known about the association between male circumcision and the risk of Chlamydia trachomatis infection in the female partner. The authors pooled data on 305 adult couples enrolled as controls in one of five case-control studies of invasive cervical cancer conducted in Thailand, the Philippines, Brazil, Colombia, and Spain between 1985 and Women provided blood samples for C. trachomatis and Chlamydia pneumoniae antibody detection; a type-specific microfluorescence assay was used. Multivariate odds ratios were computed for the association between male circumcision status and chlamydial seropositivity in women. Compared with women with uncircumcised partners, those with circumcised partners had a 5.6-fold reduced risk of testing seropositive for C. trachomatis (82 reduction; odds ratio ¼ 0.18, 95 confidence interval: 0.05, 0.58). The inverse association was also observed after restricting the analysis to monogamous women and their only male partners (odds ratio ¼ 0.21, 95 confidence interval: 0.06, 0.72). In contrast, seropositivity to C. pneumoniae, a non-sexually-transmitted infection, was not significantly related to circumcision status of the male partner. These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners. Chlamydia pneumoniae; Chlamydia trachomatis; circumcision; men; sexual behavior; sexually transmitted diseases Abbreviations: CI, confidence interval; HPV, human papillomavirus; MIF, microimmunofluorescence; OR, odds ratio. Chlamydia trachomatis are obligate intracellular bacteria that infect genital and ocular tissue. Chlamydial infections and their complications are costly and present a significant public health problem in both developed and developing countries. The World Health Organization estimates that approximately 92 million new cases of genital chlamydial infection occur worldwide annually. C. trachomatis is the most common bacterial cause of sexually transmitted Reprint requests to Dr. Xavier Castellsagué, Cancer Epidemiology and Registration Unit, Institut d Investigació Biomèdica de Bellvitge (IDIBELL), Institut Català d Oncologia, Gran via s/n, km 2.7, E L Hospitalet de Llobregat, Barcelona, Spain ( xcastellsague@ico.scs.es). 1
2 2 Castellsagué et al. infections in the United States, responsible for an estimated 3 million new infections each year and a total annual cost of $2 billion for care (1). Clinical manifestations of C. trachomatis infections in women include acute urethral syndrome, urethritis, bartholinitis, cervicitis, upper genital tract infection, perihepatitis, and reactive arthritis (1). Genital C. trachomatis infections have been clinically associated with cytologic cervical atypia and induction of cervical metaplasia (2), and they have been considered a likely human papillomavirus (HPV) cofactor that increases the risk of cervical cancer (3, 4). Untreated chlamydial infection can lead to severe reproductive complications being an important causal agent in pelvic inflammatory disease that can lead to infertility, ectopic pregnancy, and chronic pelvic pain (5). In men, the most common clinical manifestation is nongonococcal urethritis, causing approximately percent of all cases of nongonococcal urethritis in heterosexual men. Other clinical syndromes in men include acute epididymitis, acute proctitis, acute proctocolitis, conjunctivitis, and Reiter s syndrome (1). Male infertility, chronic prostatitis, and urethral strictures are possible results of infection. Infection with C. trachomatis is also believed to be a cofactor for transmission of human immunodeficiency virus in both men and women (6). Evidence from several studies suggests that male circumcision may reduce the risk of acquiring and transmitting a number of venereal diseases, including human immunodeficiency virus (7, 8). However, the few reports looking at the association between male circumcision and C. trachomatis infections in men have yielded inconsistent results (9 15). To our knowledge, the possible relation between male circumcision and C. trachomatis infection in the female partner has never been explored. We previously reported on a negative association between male circumcision and penile HPV DNA detection and, in men with multiple female sexual partners, on a reduced risk of developing cervical cancer in their spouses (16). In this report, we analyze data from a subset of couples who participated as controls in an international multicenter case-control study of invasive cervical cancer (17 27). The aim of this study was to explore the association between circumcision status and the risk of C. trachomatis infection in female sexual partners as assessed by type-specific serologic assays, using as a validity control serodetection of antibodies against Chlamydia pneumoniae, a non-sexually-transmitted infection. MATERIALS AND METHODS Study design Study subjects for these analyses were the controls enrolled in an international, multicenter case-control study of invasive cervical cancer conducted in Colombia (23, 25), Spain (18), Brazil (21), Thailand (20), and the Philippines (26) between 1985 and The study was coordinated by the International Agency for Research on Cancer. Each study used a similar protocol and questionnaire for recruitment and data collection. Details of the methods of each study have been published previously (16 27). In brief, women controls for the case-control studies were recruited from the general population in Spain and Colombia and from the same hospitals as the women cases for the other studies. In all studies, women controls were frequency matched to the cases with invasive cervical cancer according to age. Men eligible for the present study were the husbands or stable partners of the women controls enrolled in each of the case-control studies. A man was considered a stable partner of an enrolled woman if he reported having had regular sexual intercourse with the woman for at least 6 months, whether or not they were married or lived together. Selection of the final study couples included in this analysis was driven by the availability of sera and of information on circumcision status. All protocols were approved by the International Agency for Research on Cancer and the local ethics and research committees. Informed consent was obtained from all study subjects. Human experimentation guidelines of the International Agency for Research on Cancer and those of the participating institutions in Colombia, Spain, Brazil, the Philippines, and Thailand were rigorously followed. Questionnaire and medical examination Subjects were interviewed and information was collected on demographic and socioeconomic variables, sexual history, and circumcision status by use of a standardized questionnaire. As reported previously, self-reported circumcision status was assessed by a clinician for 97.4 percent of the men recruited in the studies in Brazil, Thailand, and the Philippines (16). Since the reliability between the two measures was very high (kappa ¼ 0.89), self-reported circumcision status was used for the current analyses. Detection of C. trachomatis antibodies The strategy used for Chlamydia antibody detection in women was identical to that used in two previous reports of the same study population (3, 4). Briefly, C. trachomatis immunoglobulin G antibodies were determined by a microimmunofluorescence (MIF) assay (28), considered the reference standard for chlamydial serology. MIF assays were conducted blinded to the partner s circumcision status. The antigen panel consisted of purified elementary bodies of C. trachomatis (serovar A and three pooled serovar groups of BDE, CJHI, and FGK) and C. pneumoniae, which was included to monitor cross-reactive, genus-specific antibody responses against all chlamydial species. Sera were screened for C. trachomatis at 1:8 dilution and titered to endpoint (1:8, 1:32, 1:128, >1:128). An immunoglobulin G titer of 1:8 against any C. trachomatis serovar group was considered evidence of past C. trachomatis infection. An immunoglobulin G titer of 1:16 against C. pneumoniae was considered evidence of past C. pneumoniae respiratory infections. As reported previously, from the biologic bank of the international study, sera with identical titers for all C. trachomatis and C. pneumoniae species were also tested
3 Male Circumcision and Female Chlamydial Infections 3 against Chlamydia psittaci (avian strain 6BC) to determine the presence of genus-specific antibody responses (3, 4). Sera from six cases and 11 controls with identical titers for C. trachomatis, C. pneumoniae, and C. psittaci, and from 20 cases and 23 controls who were seropositive for serovar A and negative for all other C. trachomatis serovars, were considered noninformative as to C. trachomatis serologic status and were not included in the analyses. Sera from subjects in Spain and Colombia that had already been evaluated by using a simplified MIF assay based on the L2 serovar were retested by using the MIF assay described above to improve the specificity of previous findings. Furthermore, a blinded reproducibility study based on the overall study sera was conducted by retesting a random sample of 222 specimens (9.5 percent) twice (4). Percent agreement for C. trachomatis serovars A, BDE, CJHI, and FGK and for C. pneumoniae was 85.3 percent, 86.2 percent, 86.7 percent, and 84.9 percent, and 89.3 percent, respectively. Statistical analyses Unconditional logistic regression models were fitted to individual data. Associations between male circumcision and chlamydia seropositivity were estimated by using multivariate odds ratios and their corresponding 95 percent confidence intervals. Unless otherwise specified in this report, all models were adjusted for study, man s and woman s age, and man s and woman s lifetime number of sexual partners. Stratified analyses were performed to assess the consistency of results across strata of other key variables, including condom use and cervical HPV DNA status as determined by polymerase chain reaction based assays, as described previously (29, 30). We assessed whether the association of circumcision status with woman s C. trachomatis seropositivity differed significantly according to the country in which the various studies were conducted. We did so by testing in the fully adjusted logistic regression model for an interaction term combining country and circumcision status. To rule out the possibility that potential associations between the partner s circumcision status and female chlamydial serostatus were not due to the potential contribution of other previous sexual partners, we performed further analyses restricted to monogamous women and their only male partner. Monogamy was self-reported and was defined as including only those women declaring in the interview that they had had one and only one lifetime sexual partner (n ¼ 253). For all analyses, a two-sided p value of less than 0.05 was considered to indicate statistical significance. RESULTS Study subjects Of the 1,382 women controls enrolled in one of the five case-control studies of invasive cervical cancer, 1,029 reported having a husband or stable male partner at study entry. A total of 589 of these women (57.2 percent) agreed to participate and were interviewed. Of those, 493 (83.7 percent) provided sera, and 300 (60.9 percent) and 305 (61.9 percent) of the samples were adequately tested for C. trachomatis and C. pneumoniae serology, respectively. Overall, women controls whose chlamydial serology status could be confirmed (n ¼ 305) were similar to the women whose chlamydial serology status could not be established (n ¼ 284) with respect to age, level of education, circumcision status, cervical HPV DNA status, and variables related to sexual behavior of the couple such as age at first sexual intercourse and lifetime number of sexual partners (data not shown). The overall prevalence of circumcision was 37.0 percent: 1.8 in Spain, 6.9 in Colombia, 7.4 in Brazil, 13.3 in Thailand, and 92.5 percent in the Philippines. Compared with uncircumcised men, circumcised men were younger and more likely to have a history of multiple sexual partners. No differences were noted with regard to other sexualbehavior characteristics such as age at first sexual intercourse, ever contact with prostitutes, genital hygiene, condom use, partner s age at first sexual intercourse, or partner s lifetime number of sexual partners (data not shown). Table 1 summarizes subjects characteristics according to C. trachomatis serostatus. The overall prevalence of female C. trachomatis was 28.0 percent: 16.7 in Brazil, 22.4 in the Philippines, 32.1 in Spain, 35.6 in Thailand, and 55.2 in Colombia. Compared with seronegative women, seropositive women were more likely to have had two or more sexual partners, be younger at first sexual intercourse, and have a current male partner with a history of multiple sexual partners. Male circumcision and female C. trachomatis seropositivity C. trachomatis seroprevalence was lower in women whose partners were circumcised than in women whose partners were not (figure 1). Moreover, in female partners of both circumcised and uncircumcised men, C. trachomatis seropositivity increased significantly with increasing number of sexual partners that the women had had and with increasing number of sexual partners that the men had had. In contrast, C. pneumoniae seropositivity was not significantly associated with any of these sexual-behavior indicators. Table 2 shows the multivariate odds ratios for the association between male circumcision and woman s C. trachomatis seropositivity, overall and by selected characteristics of women and their male partners. Male circumcision was strongly associated with a decrease in the risk of C. trachomatis seropositivity in female partners (odds ratio (OR) ¼ 0.18, 95 percent confidence interval (CI): 0.05, 0.58; p ¼ 0.004). Although data were scarce in Spain, Colombia, and Brazil, there was no evidence of heterogeneity of the associations with respect to study location (p ¼ 0.99). The inverse association was not substantially influenced by any of the assessed characteristics of the women or of the men except for condom use, for which the inverse association was observed among non-condom-users only. The risk reduction for C. trachomatis seropositivity linked to male
4 4 Castellsagué et al. TABLE 1. Female Chlamydia trachomatis seroprevalence by subjects characteristics and odds ratios for female seropositivity, Colombia, Spain, Brazil, Thailand, and the Philippines, Subjects characteristics C. trachomatis seropositivity positive Adjusted OR*,y 95 CI* All women 84/ Study location Thailand 16/ Philippines 24/ Brazil 11/ Colombia 16/ Spain 17/ Educational level attained Secondary or higher 25/ Reference None or primary 59/ , 3.25 Unknown 0/1 Age group (years) 36 17/ Reference / , / , 2.80 Lifetime no. of sexual partners 1 62/ Reference 2 22/ z 1.32, 5.64 Age at first sexual 18 62/ Reference 17 22/ z 1.10, 5.15 Condom use No 71/ Reference Yes 13/ , 3.16 Partner s age group (years) 37 14/ Reference / , / , / , 2.68 Table continues circumcision was particularly strong among older women (OR ¼ 0.07, 95 percent CI: 0.01, 0.45), women with older male partners (OR ¼ 0.11, 95 percent CI: 0.01, 0.93), and women whose male partners reported having six or more lifetime female sexual partners (OR ¼ 0.10, 95 percent CI: 0.01, 0.82; p ¼ 0.03). After we excluded couples from Brazil, Colombia, and Spain, the summary odds ratio was 0.27 (95 percent CI: 0.07, 1.04), and the summary odds ratio after excluding couples from only the Philippines was 0.11 (95 percent CI: 0.01, 0.91). Further adjustment by socioeconomic indicators and/or condom use did not substantially alter the magnitude of the above associations (data not shown). In contrast, none of the odds ratio estimates for the association between circumcision and C. pneumoniae seropositivity in the female partner was statistically significant (table 3). DISCUSSION This study shows that adult women with current circumcised partners are less likely than women with uncircumcised partners to be seropositive for C. trachomatis antibodies. Male circumcision was associated with an overall 82 percent reduction in the risk of C. trachomatis infection in their
5 Male Circumcision and Female Chlamydial Infections 5 TABLE 1. Continued Subjects characteristics C. trachomatis seropositivity positive Adjusted ORy 95 CI Partner s lifetime no. of sexual partners 1 10/ Reference / , / , / z 1.10, 6.10 Unknown 0/4 Partner s age at first sexual 17 57/ Reference 16 27/ , 3.27 Partner s ever contacts with prostitutes Never 29/ Reference Ever 55/ , 2.40 Unknown 0/2 Partner s no. of sexual partners as prostitutes 0 29/ Reference / , / z 1.06, 4.48 Unknown 0/3 Partner s condom use with regular partner{ Yes 9/ Reference No 42/ , 2.75 Partner s circumcision status Uncircumcised 62/ Reference Circumcised 22/ z 0.06, 0.63 * OR, odds ratio; CI, confidence interval. y Adjusted by study location, age, lifetime number of sexual partners, partner s age, and partner s lifetime number of sexual partners. z Statistically significant. This model was not adjusted by partner s lifetime number of sexual partners. { Excludes subjects from Spain and Colombia. female partners as assessed by type-specific serologic assays after taking into account the lifetime number of sexual partners of the couple. The inverse association was consistently found in all countries considered, although estimates were far from precise in Spain, Colombia, and Brazil. The strongest protective effect was found in older women (OR ¼ 0.07), in women with older male partners (OR ¼ 0.11), and in women whose current stable partners reported multiple (six or more) lifetime sexual partners (OR ¼ 0.10). In contrast, younger women and women with a history of consistent condom use were part of the only two subgroups of couples in which circumcision was not associated with reduced C. trachomatis serodetection. Our study thus supports the possibility that, as reported for other sexually transmitted infections, male circumcision reduces the risk of transmitting C. trachomatis to the female partner. The validity of our results is supported by the use of a multicenter study with a fair sample size of couples for whom questionnaire and serologic data were complete, a common protocol, and standardized laboratory procedures to ascertain type-specific serum antibodies against C. trachomatis. The specificity of the observed MIF antibody responses was validated by the observation that C. trachomatis antibody responses, unlike those for C. pneumoniae, were clearly correlated with indicators of sexual behavior (figure 1). Furthermore, no associations were found between male
6 6 Castellsagué et al Chlamydia trachomatis p for trend = p for trend = Lifetime number of sexual partners Uncircumcised partner Partner s lifetime number of sexual partners Circumcised partner Chlamydia pneumoniae p for trend = p for trend = Lifetime number of sexual partners Uncircumcised partner Partner s lifetime number of sexual partners Circumcised partner FIGURE 1. Female Chlamydia trachomatis (top panel) and Chlamydia pneumoniae (bottom panel) seroprevalence by partner s circumcision status and number of sexual partners, Colombia, Spain, Brazil, Thailand, and the Philippines, circumcision and past exposure to C. pneumoniae, a nonsexually-transmitted infection, neither overall nor by any of the explored characteristics of the couples (table 3). Little reliable data are available on the natural history of C. trachomatis antibody profiles during persistent or acute infections. The stability of antibody response to a single chlamydial infection over time is difficult to study because of the asymptomatic nature of the infection and hence the difficulty in controlling for whether or how often a person has been reinfected. Although C. trachomatis antibodies have been shown to persist for years, a loss of or a decrease in immunoglobulin G antibody titers may occur over time (31, 32), particularly if there is no continued antigenic stimulation (33). Nevertheless, detection of type-specific C. trachomatis antibodies is generally accepted as a measure of lifetime exposure. To our knowledge, no studies have explored at the biologic level the mechanisms by which removal of the foreskin may reduce the risk of transmitting C. trachomatis to the partner. We speculate that a penis with a prepuce is perhaps more likely to retain infected cervicovaginal secretions for a longer duration than a penis with no prepuce, subsequently increasing the likelihood of infection to the penile urethra and transmission to the vagina during intercourse. Our study has a number of limitations that should be considered in interpreting our findings. Since cervical samples were not available because they were used for HPV testing, we could not measure current C. trachomatis infection, a piece of information that could bolster the biologic plausibility of the association. However, to explore our study hypothesis, it is more adequate and informative to measure a woman s cumulative past exposure than just current infection. A possible consequence of using chlamydial serology as a marker of past exposure is that any given woman could have acquired a previous chlamydial infection from a sexual partner other than the one included in the study. However, analyses restricted to women reporting one lifetime sexual partner also yielded an inverse and statistically significant association (OR ¼ 0.21; table 2). It should be noted that the inverse association we found between male circumcision and serodetection of C. trachomatis antibodies in female partners is at best indirect because 1) we did not ascertain chlamydial serum antibodies in the men themselves, and 2) we measured through serology the woman s lifetime exposure to chlamydial infections but used the circumcision status of the current partner. However, the lack of association that we found with C. pneumoniae antibodies is consistent with the modes of transmission of these two infections, bolstering the overall biologic plausibility of the protective effect and the validity of the study. Even if we had determined serum antibodies in men and had not found an inverse association between circumcision status and the man s seroprevalence, our findings for women
7 Male Circumcision and Female Chlamydial Infections 7 TABLE 2. Odds ratios for the association between male circumcision and female Chlamydia trachomatis seropositivity by selected subjects characteristics, Colombia, Spain, Brazil, Thailand, and the Philippines, * Subjects characteristics No. Women with uncircumcised partners C. trachomatis seropositivity seropositive Women with circumcised partners seropositive Adjusted ORy 95 CIy All women / / z 0.05, 0.58 Study location Thailand 45 15/ / , 2.99 Philippines 107 3/ / , 1.21 Brazil 66 11/ /5 0 Colombia 29 16/ /2 0 Spain 53 17/ /1 0 Age group (years) / / , / / , / / z 0.01, 0.45 Lifetime no. of sexual partners / / z 0.06, / / , 2.10 Age at first sexual / / z 0.05, / / , 4.15 Cervical HPVy DNA status{ Negative / / z 0.05, 0.58 Positive 43 10/ / , 2.96 Chlamydia pneumoniae serostatus Negative 98 24/ / , 1.29 Positive / / , 1.08 Consistent condom use No / / z 0.05, 0.60 Yes 40 10/ / , 7.25 Partner s age group (years) / / , / / z 0.03, / / z 0.01, 0.93 Partner s lifetime no. of sexual partners / / , / / z 0.01, 0.82 Partner s ever contacts with prostitutes# Never / / , 1.08 Ever / / z 0.03, 0.90 Partner s age at first sexual / / z 0.06, / / , 1.42 Partner s genital hygiene as assessed by a physician** Good / / , 1.53 Poor/medium 70 15/ / , 13.1 * Reference category for all odds ratios: seronegative women with uncircumcised partners. Models were adjusted by study, man s and woman s ages, and man s and woman s lifetime numbers of sexual partners. Totals may not add up correctly because of missing values (refer to table 1). y OR, odds ratio; CI, confidence interval; HPV, human papillomavirus. z Statistically significant. This model was not adjusted by study. { These models were not adjusted by lifetime number of sexual partners. # These models were not adjusted by partner s lifetime number of sexual partners. ** Excludes subjects from Spain and Colombia.
8 8 Castellsagué et al. TABLE 3. Odds ratios for the association between male circumcision and female Chlamydia pneumoniae seropositivity by selected subjects characteristics, Colombia, Spain, Brazil, Thailand, and the Philippines, * Subjects characteristics No. Women with uncircumcised partners C. pneumoniae seropositivity seropositive Women with circumcised partners seropositive Adjusted ORy 95 CIy All women / / , 1.94 Age group (years) / / , / / , / / , 5.14 Lifetime no. of sexual partners / / , / / z 0.24, 6.80 Age at first sexual / / , / / , 68.3 Partner s age group (years) / / , / / , / / , 11.2 Partner s lifetime no. of sexual partners / / , / / , 2.07 Partner s ever contacts with prostitutes Never / / , 2.45 Ever / / , 3.28 Partner s age at first sexual / / , / / , 3.84 * Reference category for all odds ratios: seronegative women with uncircumcised partners. Models were adjusted by study, man s and woman s ages, and man s and woman s lifetime numbers of sexual partners. Totals may not add up correctly because of missing values (refer to table 1). y OR, odds ratio; CI, confidence interval. z This model was not adjusted by study. These models were not adjusted by partner s lifetime number of sexual partners. would not be necessarily inconsistent; it is possible that male circumcision reduces the risk of transmission of the infection to the partner without reducing the risk of developing an active infection in the man himself. The fact that we could not determine chlamydial serostatus in 284 women of the 589 enrolled in the entire study might have biased our results. However, it is unlikely that male circumcision or chlamydial serostatus is related to sera availability or test adequacy. To statistically assess any evidence of selection bias, we compared subjects characteristics according to whether they had contributed a valid serologic result, and we found no statistically relevant differences between the two groups. We conclude that it is likely that the only impact of not having tested this subgroup of women concerns reduced statistical precision but not selection bias. Concerning the former, the study achieved sufficient precision not only to detect in a statistically significant manner the hypothesized inverse association but also to rule out a small effect, because the upper limit of the confidence interval of the odds ratio estimate was Finally, our results may be driven by the large contribution of circumcised men from the study in the Philippines. It is possible that the observed associations were mediated by other practices or characteristics of the recruited couples in
9 Male Circumcision and Female Chlamydial Infections 9 the Philippines that we were not able to identify or quantify. However, it is reassuring that the direction and statistical significance of the overall association remained virtually unchanged after we excluded the couples from the Philippines (OR ¼ 0.11, 95 percent CI: 0.01, 0.91). We have previously shown that male circumcision may reduce the risk of penile HPV, cervical HPV, and, in women with promiscuous partners, the risk of invasive cervical cancer (16, 34). However, one potential limitation of that study was that circumcision might be related to HPV underdetection because of inadequate penile samples from circumcised men. Since circumcision status can affect neither the availability nor the adequacy of the sera being tested for chlamydial serology, our current results further strengthen our previous findings on HPV and cervical cancer. The consistency of our results for four sexually transmitted diseases (penile HPV, cervical HPV, cervical cancer, and C. trachomatis) found in the same study provides strong support for the idea that male circumcision may indeed reduce the risk of acquisition and/or transmission of a number of sexually transmitted infections. In conclusion, this study suggests that male circumcision reduces the risk of transmission of C. trachomatis to the female partner as determined by serology. Given that C. trachomatis is the most common bacterial sexually transmitted infection both worldwide (35) and in the United States (36), further data from other studies and populations using additional markers of chlamydial infection are needed to confirm this first known epidemiologic report on this inverse association and to assess potential public health implications of these findings. ACKNOWLEDGMENTS This investigation was supported by the European Community (CI F(CD)); The Fondo de Investigaciones Sanitarias (FIS), Spain (86/753, 87/1513, 88/2049, 90/0901, 95/0955, 01/1236, and 01/1237); the International Agency for Research on Cancer, Lyon, France (FI/92/3-2 PAR); Programa Interministerial de Investigación y Desarrollo, Spain (SAF 96/0323); The Rockefeller Foundation (PS 9824); and the Department of Reproductive Health and Research at the World Health Organization (grant ). Each of the authors contributed to this report in the following ways. Dr. Xavier Castellsagué envisioned the hypothesis, initiated and coordinated the analysis, and wrote the manuscript. Dr. Rosanna W. Peeling was in charge of the chlamydial serologic assays and the writing of the serologic methods section, and she made substantial contributions in interpreting and discussing the results and in writing and obtaining final approval of the manuscript. Dr. Jennifer S. Smith contributed in obtaining funding to perform serologic assays, in the discussion of the results, and in the writing of the manuscript. Dr. Silvia de Sanjosé contributed in the interpretation and discussion of results, in the coordination of several of the case-control studies, and in the writing of the manuscript. Drs. Silvia Franceschi, Rolando Herrero, Nubia Muñoz, and F. Xavier Bosch were the principal investigators of one or several of the included studies. They developed the protocols, obtained funding for fieldwork and testing of biologic samples, supervised analyses, and contributed toward revision and final approval of the manuscript. Ginesa Albero and Mireia Díaz performed data management tasks, carried out most statistical analyses, produced tables and graphs, and contributed in the interpretation and discussion of the results. All authors had full access to all study data and had final responsibility for submitting the manuscript for publication. The authors are indebted to the gynecologists, pathologists, and oncologists who helped identify the participants and facilitated their contributions and to the fieldwork supervisors. They thank L. Dillon for the MIF C. trachomatis serologic laboratory work and F. Odefrey and Y. Guy for handling the serum specimens. The IARC Multicenter Cervical Cancer Study Group is composed of the following additional researchers: Dr. M. Plummer (International Agency for Research on Cancer, Lyon), France; Drs. V. Moreno (Institut Català d Oncologia, Barcelona), L. C. González (Servicio Territorial de Sanidad y Bienestar Social, Salamanca), M. Gili (Universidad de Sevilla, Sevilla), I. Izarzugaza (Euskadi Cancer Registry, Vitoria-Gasteiz), P. Viladiu (Registre de Càncer de Catalunya, Barcelona), C. Navarro (Consejería de Sanidad, Murcia), A. Vergara (Servicio Provincial de Sanidad, Zaragoza), N. Ascunce (Programa de Cáncer de Mama, Pamplona), and M. Santamaria (Navarra Hospital, Pamplona), Spain; Dr. P. J. Snijders (Free University Hospital, Amsterdam), the Netherlands; Drs. L. Tafur and N. Aristizabal (Universidad del Valle, Cali), Colombia; Dr. P. Alonso de Ruiz (General Hospital of Mexico, Mexico), Mexico; Dr. S. Chichareon (Prince of Songkla University, Hat-Yai), Thailand; Dr. C. Ngelangel (University of the Philippines, Manila), the Philippines; and Dr. J. Eluf-Neto (Universidade de Sao Paulo, Sao Paulo), Brazil. Part of the information included in this manuscript was presented at an invited lecture at the 21st International Papillomavirus Conference in Mexico City, Mexico, February 20 26, No abstract is available. None of the authors or authors institutions has financial or personal relationships with individuals or organizations that may bias the appropriate conducting and reporting of this research. REFERENCES 1. Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med 2003;349: Kiviat NB, Paavonen JA, Brockway J, et al. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA 1985;253: Smith JS, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002;185: Smith JS, Bosetti C, Muñoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431 9.
10 10 Castellsagué et al. 5. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19: Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75: Weiss GN. Prophylactic neonatal surgery and infectious diseases. Pediatr Infect Dis J 1997;16: Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision a systematic review with assessment of the quality of studies. Lancet Infect Dis 2005;5: Aynaud O, Piron D, Bijaoui G, et al. Developmental factors of urethral human papillomavirus lesions: correlation with circumcision. BJU Int 1999;84: Cook LS, Koutsky LA, Holmes KK. Circumcision and sexually transmitted diseases. Am J Public Health 1994;84: Diseker RA III, Peterman TA, Kamb ML, et al. Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect 2000;76: Hart G. Factors associated with genital chlamydial and gonococcal infection in males. Genitourin Med 1993;69: Oliver JC, Oliver RT, Ballard RC. Influence of circumcision and sexual behaviour on PSA levels in patients attending a sexually transmitted disease (STD) clinic. Prostate Cancer Prostatic Dis 2001;4: Serour F, Samra Z, Kushel Z, et al. Comparative periurethral bacteriology of uncircumcised and circumcised males. Genitourin Med 1997;73: Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992;267: Castellsagué X, Bosch FX, Muñoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346: Bosch FX, Muñoz N, de Sanjosé S, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2: Bosch FX, Castellsagué X, Muñoz N, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996;88: Castellsagué X, Ghaffari A, Daniel RW, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997;176: Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90: Eluf-Neto J, Booth M, Muñoz N, et al. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: Franceschi S, Castellsagué X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002;86: Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52: Muñoz N, Bosch FX, de Sanjosé S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2: Muñoz N, Castellsagué X, Bosch FX, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a highrisk area for the disease. J Natl Cancer Inst 1996;88: Ngelangel C, Muñoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90: Bosch FX, Muñoz N, de Sanjosé S, et al. Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. Cancer Epidemiol Biomarkers Prev 1994;3: Wang SP, Grayston JT. Micro immunofluorescence antibody responses in Chlamydia trachomatis infection. A review. In: Mardh PA, Holmes KK, Oriel JD, et al, eds. Chlamydial infections. Amsterdam, the Netherlands: Elsevier Biomedical Press, 1982: Manos MM, Wright DK, Lewis AJ, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Molecular diagnostics of human cancer. New York, NY: Cold Spring Harbor Press, 1989: Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3# ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76(pt 4): Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997;175: Puolakkainen M, Vesterinen E, Purola E, et al. Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol 1986;23: Ngeow YF. Limitations of serodiagnosis in chlamydial genital tract infections. Ann Acad Med Singapore 1996;25: Castellsagué X, Bosch FX, Muñoz N. The male role in cervical cancer. Salud Publica Mex 2003;45(suppl 3):S345 S World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview & estimates. Geneva, Switzerland: World Health Organization, (WHO/CDS/CSR/EDC/ ). ( hiv/pub/sti/en/who_hiv_aids_ pdf). 36. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2000 supplement: Chlamydia Prevalence Monitoring Project. Atlanta, GA: US Department of Health and Human Services, CDC, 2001.
The New England Journal of Medicine
The New England Journal of Medicine Copyright 22 by the Massachusetts Medical Society VOLUME 346 A PRIL 11, 22 NUMBER 15 MALE CIRCUMCISION, PENILE HUMAN PAPILLOMAVIRUS INFECTION, AND CERVICAL CANCER IN
More informationEpidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
The new england journal of medicine original article Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer Nubia Muñoz, M.D., F. Xavier Bosch, M.D., Silvia de Sanjosé,
More informationARTICLES. Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
ARTICLES Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention Xavier Castellsagué, Mireia Díaz, Silvia de Sanjosé, Nubia Muñoz,
More informationEffect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study Victor Moreno, F Xavier Bosch, Nubia Muñoz, Chris J L M Meijer,
More informationThe Korean Journal of Cytopathology 15 (1) : 17-27, 2004
5 The Korean Journal of Cytopathology 5 () : 7-7, / 5 / / (human papillomavirus, HPV), 6%, 5% HPV. HPV HPV. HPV HPV,,5 HPV HPV. HPV, 6 HPV. HPV HPV International Agency for Research on Cancer (IARC) HPV
More informationT here are an estimated cases of gonorrhoea annually
124 ORIGINAL ARTICLE Gonorrhoea reinfection in heterosexual STD clinic attendees: longitudinal analysis of risks for first reinfection S D Mehta, E J Erbelding, J M Zenilman, A M Rompalo... See end of
More informationTransmission from the Oropharynx to the Urethra among Men who have Sex with Men
MAJOR ARTICLE Chlamydia trachomatis and Neisseria gonorrhoeae Transmission from the Oropharynx to the Urethra among Men who have Sex with Men Kyle T. Bernstein, 1 Sally C. Stephens, 1 Pennan M. Barry,
More informationTitle: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
Author's response to reviews Title: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women Authors: Jia Ji (jackie.j.ji@gmail.com) He Wang (hewangpeking@gmail.com) Jennifer S. Smith
More informationUnprotected sex in an STD clinic population: Agreement between self-reported condom use and PCR detection of y-chromosome in vaginal fluid
Unprotected sex in an STD clinic population: Agreement between self-reported condom use and PCR detection of y-chromosome in vaginal fluid Alia A. Al-Tayyib, MSPH 1, William C. Miller, MD, PhD, MPH 1,2,
More informationLong-Term Pill Use, High Parity Raise Cervical Cancer Risk Among Women with Human Papillomavirus Infection
D I G E S T S Long-Term Pill Use, High Parity Raise Cervical Cancer Risk Among Women with Human Papillomavirus Infection Use of oral contraceptives for five years or more appears to raise the risk of cervical
More informationTrends in Reportable Sexually Transmitted Diseases in the United States, 2007
Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public
More information2. Studies of Cancer in Humans
346 IARC MONOGRAPHS VOLUME 72 2. Studies of Cancer in Humans 2.1 Breast cancer 2.1.1 Results of published studies Eight studies have been published on the relationship between the incidence of breast cancer
More informationHPV Transmission. Rachel Winer, PhD, MPH Department of Epidemiology University of Washington
HPV Transmission Rachel Winer, PhD, MPH Department of Epidemiology University of Washington rlw@u.washington.edu Disclosure Information I have no financial relationships to disclose. Human Papillomavirus
More informationThe epidemiology of human papillomavirus infection and cervical cancer
Disease Markers 23 (2007) 213 227 213 IOS Press The epidemiology of human papillomavirus infection and cervical cancer F. Xavier Bosch and Silvia de Sanjosé Institut Català d Oncologia, Epidemiology and
More informationGSK Medication: Study No.: Title: Rationale: Phase: Study Period Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationHPV AND CERVICAL CANCER
HPV AND CERVICAL CANCER DR SANDJONG TIECHOU ISAAC DELON Postgraduate Training in Reproductive Health Research Faculty of Medicine, University of Yaoundé 2007 INTRODUCTION CERVICAL CANCER IS THE SECOND
More informationFactors associated with human papillomavirus (HPV) infection in men in Brazil, Mexico, and the United States
Oregon Health & Science University OHSU Digital Commons Scholar Archive October 2011 Factors associated with human papillomavirus (HPV) infection in men in Brazil, Mexico, and the United States Alexandra
More informationPrevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea
RESEARCH COMMUNICATION Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea Kidong Kim 1, Jin Ju Kim 2,3, Sun Mie
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSources of repeat Chlamydia trachomatis infections:
Sources of repeat Chlamydia trachomatis infections: The importance of different sex partners revealed by a behavioral and molecular epidemiologic approach Linda M. Niccolai, PhD Associate Professor, Yale
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationThe male role in cervical cancer
The male role in cervical cancer Xavier Castellsagué, MD, MPH, PhD, (1) F Xavier Bosch, MD, PhD, (1) Nubia Muñoz, MD, MPH. (2) Men and cervical cancer Castellsagué X, Bosch FX, Muñoz N. The male role in
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationAdolescent HPV Prevalence Survey
November 2004 Page 1 of 7 Adolescent HPV Prevalence Survey FOLLOW-UP QUESTIONNAIRE Family/Given Name Initials HPV U Study number Study number OS/IN NTIHC number Date of Interview: Date first seen: (dd/mm/yy)
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More informationHPV Epidemiology and Natural History
HPV Epidemiology and Natural History Rachel Winer, PhD, MPH Associate Professor Department of Epidemiology University of Washington School of Public Health rlw@uw.edu Human Papillomavirus (HPV) DNA virus
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationHPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions
British Journal of Cancer (2005) 92, 1388 1392 All rights reserved 0007 0920/05 $30.00 www.bjcancer.com HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile
More informationFREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION
Arch. Biol. Sci., Belgrade, 66 (4), 1653-1658, 2014 DOI:10.2298/ABS1404653M FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION IN WOMEN IN MONTENEGRO GORDANA MIJOVIĆ 1, TATJANA JOVANOVIĆ
More informationPromoting Cervical Screening Information for Health Professionals. Cervical Cancer
Promoting Cervical Screening Information for Health Professionals Cervical Cancer PapScreen Victoria Cancer Council Victoria 1 Rathdowne St Carlton VIC 3053 Telephone: (03) 635 5147 Fax: (03) 9635 5360
More informationPathology of the Cervix
Pathology of the Cervix Thomas C. Wright Pathology of the Cervix Topics to Consider Burden of cervical cancer 1 Invasive Cervical Cancer Cervical cancer in world Second cause of cancer death in women Leading
More informationHUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY
Int. J. Cancer: 85, 486 491 (2000) 2000 Wiley-Liss, Inc. Publication of the International Union Against Cancer HUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY Pedro A. ROLÓN 1,
More informationBuve, A., H. A. Weiss, et al. (2001). The epidemiology of trichomoniasis in women in four African cities. Aids 15 Suppl 4: S89-96.
Behets, F., J. Andriamiadana, et al. (2001). Sexually transmitted infections and associated socio-demographic and behavioural factors in women seeking primary care suggest Madagascar's vulnerability to
More informationThe prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics in Hong Kong
Hong Kong J. Dermatol. Venereol. (2011) 19, 6-13 Original Article The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics
More informationThe promise of HPV vaccines for Cervical (and other genital cancer) prevention
The promise of HPV vaccines for Cervical (and other genital cancer) prevention CONTROVERSIES IN OBSTETRICS GYNECOLOGY & INFERTILITY Barcelona March 27 F. Xavier Bosch Catalan Institute of Oncology CURRENT
More information4. Chlamydia. Treatment: Treating infected patients prevents further transmission to sex partners. In addition, treatment of chlamydia in pregnant
Photomicrograph of Chlamydia trachomatis, taken from a urethral scrape. 4. Chlamydia Chlamydia trachomatis infection is the most commonly reported sexually transmitted disease (STD) in the United States,
More informationHUMAN PAPILLOMAVIRUS INFECTION IN WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS
HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS XIAO-WEI SUN, M.D., LOUISE KUHN, PH.D., TEDD V. ELLERBROCK, M.D., MARY ANN CHIASSON, DR.P.H., TIMOTHY J. BUSH, B.A.,
More informationRapid Diagnosis of Chlamydial Infection in Young Women at Reproductive Age
Feb. 2012, Volume 9, No. 2 (Serial No. 87), pp. 112 116 Journal of US-China Medical Science, ISSN 1548-6648, USA D DAVID PUBLISHING Rapid Diagnosis of Chlamydial Infection in Young Women at Reproductive
More informationGlobal incidence and prevalence of selected curable sexually transmitted infections 2008
Global incidence and prevalence of selected curable sexually transmitted infections 8 ii Global incidence and prevalence of selected curable sexually transmitted infections 8 Contents Acknowledgements...1
More informationForsyth County, North Carolina 2012 HIV/STD Surveillance Report
Forsyth County, North Carolina 2012 HIV/STD Surveillance Report Forsyth County Department of Public Health Division of Epidemiology and Surveillance 799 N. Highland Avenue Winston-Salem, NC 27102-0686
More informationCONDOM USE PROMOTES REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CLEARANCE OF HUMAN PAPILLOMAVIRUS: A RANDOMIZED CLINICAL TRIAL
Int. J. Cancer: 107, 811 816 (2003) 2003 Wiley-Liss, Inc. Publication of the International Union Against Cancer CONDOM USE PROMOTES REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CLEARANCE OF HUMAN
More informationo Changes since 1999 policy statement and 2005 update
Circumcision A Review of AAP Task Force Recommendations from August of 2012 Objectives Review AAP recommendations on circumcision o Changes since 1999 policy statement and 2005 update Be able to discuss
More informationMSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs
Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient
More informationTrends in STDs among Young People in New York State
Trends in STDs among Young People in New York State Kris Mesler, Bureau of Child and Adolescent Health Alison Muse, Bureau of Sexually Transmitted Disease Control New York State Department of Health Figure
More informationForsyth County, North Carolina 2013 HIV/STD Surveillance Report
Forsyth County, North Carolina 2013 HIV/STD Surveillance Report Forsyth County Department of Public Health Division of Epidemiology and Surveillance 799 N. Highland Avenue Winston-Salem, NC 27102-0686
More informationSexually Transmitted Diseases. Chlamydial. infection. Questions and Answers
Sexually Transmitted Diseases Chlamydial infection Questions and Answers What is chlamydial infection? It is a sexually transmitted infection caused by the bacteria Chlamydia trachomatis, being one of
More informationSexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
More informationMAJOR ARTICLE. Human papillomavirus (HPV) is the cause of cervical cancer and is associated with penile cancer, other anogenital
MAJOR ARTICLE Associations between Male Anogenital Human Papillomavirus Infection and Circumcision by Anatomic Site Sampled and Lifetime Number of Female Sex Partners Carrie M. Nielson, 1 Melody K. Schiaffino,
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More information- ii - Rights c
- ii - Rights c - iii - Preface Preface to the third edition Since the first edition of the HPV Information Centre, GLOBOCAN, one of the landmark products of the International Agency for Research on Cancer
More informationSilvia Franceschi Infections and Cancer Epidemiology Group International Agency for Research on Cancer Lyon, France
From epidemiology to cancerpreventing vaccines: the example of HPV Silvia Franceschi Infections and Cancer Epidemiology Group International Agency for Research on Cancer Lyon, France Milan, 19 March 2007
More informationHPV vaccine perspectives Dr. David Prado Cohrs
HPV vaccine perspectives Dr. David Prado Cohrs Universidad Francisco Marroquín, Guatemala President of the Sexually Transmitted Diseases Committee, SLIPE Disclosure statement The presenter has received
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationImportance of Viral Suppression to Reduce HIV Transmission: Recent Evidence
Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine Viral suppression
More informationMedicare Adds New Screening Services for Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) March 2016
Medicare Adds New Screening Services for Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) March 2016 On February 5, 2016, CMS released change requests announcing the addition of HPV and
More informationToward global prevention of sexually transmitted infections: the need for STI vaccines
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS Toward global prevention of sexually transmitted infections: the need for STI vaccines
More informationHuman Papillomavirus Detection by Penile Site in Young Men From Kenya
Sexually Transmitted Diseases, November 2007, Vol. 34, No. 11, p.000 000 DOI: 10.1097/OLQ.0b013e318065b8ef Copyright 2007, American Sexually Transmitted Diseases Association All rights reserved. Human
More informationLow grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women
British Journal of Cancer (2002) 87, 1417 1421 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women
More informationSCCPS Scientific Committee Position Paper on HPV Vaccination
SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical
More informationClinical Performance of Roche COBAS 4800 HPV Test
JCM Accepts, published online ahead of print on 9 April 2014 J. Clin. Microbiol. doi:10.1128/jcm.00883-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 1 2 3 4 5 6 Clinical
More informationFamily Planning Title X Chlamydia Screening Quality Improvement Project
Family Planning Title X Chlamydia Screening Quality Improvement Project Illinois Department of Public Health STD Section Staff March 22, 2017 Objectives Discuss current STD trends and epidemiology of chlamydia
More informationEpidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica
MAJOR ARTICLE Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica Rolando Herrero, 1,a Philip E. Castle, 2,a Mark Schiffman, 2 M. Concepción
More informationOriginal Study. Culture of Non-Genital Sites Increases the Detection of Gonorrhea in Women
J Pediatr Adolesc Gynecol (2010) 23:246e252 Original Study Culture of Non-Genital Sites Increases the Detection of Gonorrhea in Women Courtney M. Giannini 1, Hye K. Kim, BS 1, Jonathan Mortensen 3, Joel
More informationSummary Guidelines for the Use of Herpes Simplex Virus (HSV) Type 2 Serologies
Summary Guidelines for the Use of Herpes Simplex Virus (HSV) Type 2 Serologies Genital herpes is one of the most prevalent sexually transmitted diseases, affecting more than one in five sexually active
More informationACKNOWLEDGEMENTS FOR FURTHER INFORMATION
ACKNOWLEDGEMENTS This report details the descriptive epidemiology of chlamydia and gonorrhea in the Winnipeg Health Region. Special gratitude is extended to the following individuals: Communicable Disease
More informationPrevalence of Penile Human Papillomavirus DNA in Husbands of Women with and without Cervical Neoplasia: A Study in Spain and Colombia
353 Prevalence of Penile Human Papillomavirus DNA in Husbands of Women with and without Cervical Neoplasia: A Study in Spain and Colombia X. Castellsagué, A. Ghaffari, R. W. Daniel, F. X. Bosch, Servei
More informationSexual relationships, risk behaviour, and condom
368 Original article Department of Genitourinary Medicine, Charing Cross Hospital, Fulham Palace Road, London W6 8RF B A Evans Charing Cross and Westminster Medical School, Charing Cross Hospital, London
More informationHuman Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses
More informationReducing the Sexual Transmission of Genital Herpes
CLINICAL GUIDELINE Reducing the Sexual Transmission of Genital Herpes Compiled by Adrian Mindel Introduction People diagnosed with genital herpes usually have many questions and concerns, a key one being
More informationRisk factors for the acquisition of genital warts: are condoms protective?
312 Sex Transm Inf 1999;75:312 316 Original article Academic Unit of Sexual Health Medicine, Sydney Hospital, Sydney, Australia LMWen C S Estcourt A Mindel Department of Public Health and Community Medicine,
More informationChlamydia, Gardenerella, and Ureaplasma
Chlamydia, Gardenerella, and Ureaplasma Dr. Hala Al Daghsitani Chlamydia trachomatis is a Gram negative with LPS, obligate intracellular life cycle, associated with sexually transmitted disease (STD).
More informationLargest efficacy trial of a cervical cancer vaccine showed Cervarix protects against the five most common cancercausing
FOR IMMEDIATE RELEASE Largest efficacy trial of a cervical cancer vaccine showed Cervarix protects against the five most common cancercausing virus types Published in The Lancet: Additional efficacy could
More informationWorkshop Summary: Scientific Evidence on Condom Effectiveness. for Sexually Transmitted Disease (STD) Prevention. June 12-13, 2000
Workshop Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention June 12-13, 2000 Hyatt Dulles Airport Herndon, Virginia This summary report was prepared
More informationPerceived Risk of Chlamydial and Gonococcal Infection Among Sexually Experienced Young Adults In the United States
Among Sexually Experienced Young Adults In the United States By Carol A. Ford, James Jaccard, Susan G. Millstein, Philip E. Bardsley and William C. Miller Carol A. Ford is associate professor, Departments
More informationCervical screening. Cytology-based screening programmes
HPV-FASTER: broadening the scope for prevention of HPV-related cancer Combining the complementary approaches of HPV vaccination and screening could accelerate declines in the burden of cervical cancer
More informationCHLAMYDIA TRACHOMATIS IN CANADA: AN UPDATE
Vol. 23 15 Date of publication: 1 August 1997 Contained in this issue: (No. of pages: 5) Official page numbers: For reference purposes, CHLAMYDIA TRACHOMATIS IN CANADA: AN UPDATE.............. F-1 113-120
More informationReceptive Anal Intercourse and HIV Infection
World Journal of AIDS, 2017, 7, 269-278 http://www.scirp.org/journal/wja ISSN Online: 2160-8822 ISSN Print: 2160-8814 Receptive Anal Intercourse and HIV Infection Gilbert R. Lavoie 1, John F. Fisher 2
More informationChapter 2: Disease Burden and Cervical Screening in Ontario
Chapter 2: Disease Burden and Cervical Screening in Ontario Learning Objectives On completion of this section, the learner will be able to: 1. Understand human papillomavirus, disease burden, cervical
More information9/18/2008. Cervical Cancer Prevention for Adolescent Populations Garcia. Faculty disclosure. Objectives. HPV Positivity by Age (UK)
Faculty disclosure Cervical Cancer Prevention for Francisco, MD, MPH Associate Professor Obstetrics & Gynecology Mexican American Studies Public Health Francisco, MD, MPH has no financial affiliations
More informationBackground HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou
Case-Control Control Study of Human Papillomavirus avi and Oropharyngeal Cancer D Souza, DSouza, et al. NEJM, May 2007 Tony Sung Julia Beaver Journal Club September 9, 2009 Background HPV causes virtually
More informationConcurrent and Sequential Acquisition of Different Genital Human Papillomavirus Types
1097 Concurrent and Sequential Acquisition of Different Genital Human Papillomavirus Types Katherine K. Thomas, 1 James P. Hughes, 1 Jane M. Kuypers, 2 Nancy B. Kiviat, 2 Shu-Kuang Lee, 1 Diane E. Adam,
More informationRESEARCH ON AIDS IN LATIN AMERICA AND THE CARIBBEAN
ACHR 29/93.10 Original: Spanish RESEARCH ON AIDS IN LATIN AMERICA AND THE CARIBBEAN Division of Communicable Diseases Prevention and Control Program of AIDS and Sexually Transmitted Diseases July 1993.1..
More informationSurvey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX
European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory
More informationMenu and flexibility with the QIAscreen HPV PCR Test
Menu and flexibility with the QIAscreen HPV PCR Test Sample to Insight HPV and Cervical cancer Worldwide, HPV is one of the most common STIs Persistent infection with high-risk HPV types is linked to virtually
More informationThe epidemiology of Chlamydia trachomatis infection. Chlamydia trachomatis Infection in Asymptomatic Men. Background
Chlamydia trachomatis Infection in Asymptomatic Men D. Scott LaMontagne, MPH, David N. Fine, PhD, Jeanne M. Marrazzo, MD, MPH Background: Methods: Results: Conclusions: The epidemiology of Chlamydia trachomatis
More informationChlamydia. By Madhuri Reddy
Chlamydia By Madhuri Reddy Disease- Chlamydia Etiologic agent Chlamydial infection is caused by the genera Chlamydia, of which the type of species is Chlamydia trachomatis. This infection can causes diseases
More informationand treating joins with the top of canal). at risk for cervical carcinomas, cervix.
CERVICAL CANCER Worldwide, cervical cancer is twelfth most common and the fifth most deadly cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year. Cervical
More informationOBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections
Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections OBJECTIVES I. Appreciate the changing epidemiology of trichomoniasis and clinician ordering patterns on the basis of improved
More informationSTD Epidemiology. Jonathan Zenilman, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationShrestha P CORRESPONDENCE
NJOG 2015 Jul-Dec; 20 (2):45-49 Original Article Shrestha P 1 2 2 1 Department of Obstetrics and Gynecology, Patan Academy of Health Science, Lalitpur, 2 Department of Obstetrics and Gynecology, Tribhuvan
More informationChlamydia trachomatis IgG antibodies. TAT: 7-10 days, Germany. Units: U/ml
Chlamydia General: Chlamydia belong to small bacteria, they grow obligatorily intracellularly and some Chlamydia belong to sexually transmitted diseases (STDs). Transmission also occurs through animals.
More informationBiology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)
Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) STI s once called venereal diseases More than 20 STIs have now been identified most prevalent among teenagers and young adults.
More informationSexual behavior survey and screening for chlamydia and gonorrhea in university students in South Korea
Blackwell Science, LtdOxford, UKIJUInternational Journal of Urology1442-20422005 Blackwell Publishing Asia Pty LtdFebruary 2005122187193Original ArticleChlamydia and gonorrhea in students in South KoreaS-J
More informationEmerging Laboratory Diagnostic Options for Sexually-transmitted Infections
Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections Erik Munson Wheaton Franciscan Laboratory Marquette University Milwaukee, Wisconsin 1 OBJECTIVES I. Appreciate the changing epidemiology
More informationTrends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems
Trends in STDs: US Perspective Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems Outline Overview of STD Epidemiology and Current Situation in US Overview of Chlamydia infections
More informationHPV is the most common sexually transmitted infection in the world.
Hi. I m Kristina Dahlstrom, an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. My lecture today will be on the epidemiology of oropharyngeal
More informationKey words : Chlamydia trachomatis, Tonsillitis, Rokitamycin
Key words : Chlamydia trachomatis, Tonsillitis, Rokitamycin Table 1 Distribution of the study population Table 2 Clinical details of patients with tonsillitis *LT =Lingering tonsillitis, RT = Recurrent
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011
Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationPrediagnostic Circulating Polyomavirus Antibody Levels and Risk of non-hodgkin
Prediagnostic Circulating Polyomavirus Antibody Levels and Risk of non-hodgkin Lymphoma Lauren R. Teras 1, Dana E. Rollison 2, Michael Pawlita 3, Angelika Michel 3, Jennifer L. Blase 1, Martina Willhauck-Fleckenstein
More informationWhat you need to know to: Keep Yourself SAFE!
What you need to know to: Keep Yourself SAFE! What are sexually transmitted diseases (STDs)? How are they spread? What are the different types of STDs? How do I protect myself? STDs are infections or diseases
More information